Timothy Eugene Sullivan insider trades
Open-market stock purchases and sales by Timothy Eugene Sullivan, Chief Financial Officer at Apellis Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 16, 2018.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +38%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2.1M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $3.1M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2.3M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2.3M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $2.3M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.2M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $358K |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.6M |
| Apr 17, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 28, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 22, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $224K |
Companies traded
- APLS Apellis Pharmaceuticals, Inc: 1 buy, 26 sales, last May 14, 2026
Get free alerts when Timothy Eugene Sullivan files a new trade →